The Scientist quotes William Jacobs Jr., Ph.D., on the development of tuberculosis infections in humans on immune-boosting cancer treatments. Dr. Jacobs is professor of microbiology & immunology and of genetics and the Leo and Julia Forchheimer Chair in Microbiology & Immunology at Einstein.


Science News interviews Betsy Herold, M.D., about her new research with William Jacobs, Jr., Ph.D., on an experimental herpes vaccine. Dr. Herold explains that their novel approach was to silence the loud, or dominant, surface protein on the virus in order to use the other proteins to trigger an effective immune response. Dr. Herold holds the Harold and Muriel Block Chair in Pediatrics at Einstein and is the chief of the division of pediatric infectious diseases at the Children's Hospital at Montefiore and Einstein. Dr. Jacobs is a Howard Hughes Medical Institute Investigator and the Leo and Julia Forchheimer Chair in Microbiology & Immunology at Einstein.


In a Nautilus profile, Dr. William Jacobs, Jr., discusses the key breakthroughs in his tuberculosis research and how losing his vision impacted his career path. The feature also includes an audio interview and animation of Dr. Jacobs talking about his shift from mathematics to bacterial genetics, his desire to help the underprivileged, and his goal to see the eradication of TB in his lifetime. Dr. Jacobs is professor of microbiology & immunology and of genetics at Einstein and a Howard Hughes Medical Institute investigator.


BBC News features surprising new research by William Jacobs, Jr., Ph.D., that found vitamin C kills multidrug-resistant tuberculosis in lab tests. Dr. Jacobs notes that further study is needed because the findings have not yet been shown to work in humans. Dr. Jacobs is professor of microbiology & immunology and of genetics at Einstein and a Howard Hughes Medical Institute investigator.

More coverage on this story

The Scientist
Medscape
MedPage Today
Agence France Presse
ABC Radio (Australia)
The Times of India
The Calcutta Telegraph (India)
ANSA (Italy)
Scientific American
Mint (India)


The American Association for the Advancement of Science features William Jacobs, Jr., Ph.D., dubbed the “TB Terminator,” on its “Member Spotlight” blog. The profile highlights Dr. Jacobs’ pioneering use of molecular genetics to control TB, his drive to discover a new vaccine and his work to encourage student interest – from high school to the master’s level – in science. Dr. Jacobs is professor of microbiology & immunology and of genetics at Einstein and a Howard Hughes Medical Institute investigator.


TheScientist features an inexpensive new test developed by William Jacobs, Jr., Ph.D., and a team of researchers that quickly detects tuberculosis and determines whether it is drug resistant, a process that currently takes months and may result in death. Dr. Jacobs is professor of microbiology & immunology and of genetics at Einstein and a Howard Hughes Medical Institute investigator.


BBC News (UK) interviews William Jacobs, Jr., Ph.D., about his new study that identifies a promising new vaccine to protect against tuberculosis. Dr. Jacobs is professor of microbiology & immunology and of genetics at Einstein and a Howard Hughes Medical Institute investigator.

More coverage on this story

The Independent (UK)
Agence France-Presse
Agenzia Italia (Italy)
UPI


The Financial Times (UK) features research by William Jacobs, Jr., Ph.D., that identifies two new ways to fight tuberculosis (TB), a disease responsible for an estimated two million deaths each year. Dr. Jacobs' work uncovered enzymes that, when disabled, lead the bacteria that causes TB to self-destruct. Dr. Jacobs is professor of microbiology & immunology and of genetics at Einstein and a Howard Hughes Medical Institute investigator. (Log in required)

More coverage on this story

Telegraph (UK)
UPI
BBC Mundo (in Spanish)